Correlation Between Molecular Templates and Leap Therapeutics
Can any of the company-specific risk be diversified away by investing in both Molecular Templates and Leap Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Templates and Leap Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Templates and Leap Therapeutics, you can compare the effects of market volatilities on Molecular Templates and Leap Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Templates with a short position of Leap Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Templates and Leap Therapeutics.
Diversification Opportunities for Molecular Templates and Leap Therapeutics
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Leap is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Templates and Leap Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Leap Therapeutics and Molecular Templates is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Templates are associated (or correlated) with Leap Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Leap Therapeutics has no effect on the direction of Molecular Templates i.e., Molecular Templates and Leap Therapeutics go up and down completely randomly.
Pair Corralation between Molecular Templates and Leap Therapeutics
Given the investment horizon of 90 days Molecular Templates is expected to generate 4.55 times more return on investment than Leap Therapeutics. However, Molecular Templates is 4.55 times more volatile than Leap Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Leap Therapeutics is currently generating about -0.46 per unit of risk. If you would invest 50.00 in Molecular Templates on August 28, 2024 and sell it today you would lose (10.00) from holding Molecular Templates or give up 20.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Molecular Templates vs. Leap Therapeutics
Performance |
| Timeline |
| Molecular Templates |
| Leap Therapeutics |
Molecular Templates and Leap Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Templates and Leap Therapeutics
The main advantage of trading using opposite Molecular Templates and Leap Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Templates position performs unexpectedly, Leap Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Leap Therapeutics will offset losses from the drop in Leap Therapeutics' long position.| Molecular Templates vs. Eliem Therapeutics | Molecular Templates vs. HCW Biologics | Molecular Templates vs. Scpharmaceuticals | Molecular Templates vs. Milestone Pharmaceuticals |
| Leap Therapeutics vs. X4 Pharmaceuticals | Leap Therapeutics vs. Terns Pharmaceuticals | Leap Therapeutics vs. Day One Biopharmaceuticals | Leap Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |